Literature DB >> 9754514

Effect of histamine-2 receptor antagonists on blood alcohol levels: a meta-analysis.

D S Weinberg1, D Burnham, J A Berlin.   

Abstract

OBJECTIVE: To determine the effect, if any, of histamine type 2 receptor antagonists (H2RAs) on serum alcohol levels under various conditions including type of H2RA receptor antagonist, alcohol dose, and fed status of the subject. STUDY
DESIGN: Meta-analysis of the published literature. DATA SOURCES: Studies were identified by MEDLINE (January 1982 through December 1997) using the key words H2 receptor antagonists and alcohol. Other studies were identified by reviewing bibliographies of retrieved articles and by discussion with colleagues. STUDY SELECTION: Studies were selected if they involved the coadministration of H2RAs and alcohol in healthy, human volunteers. Studies that may have addressed this goal but were performed in another context, for instance the measurement of ulcer healing, were excluded. DATA EXTRACTION: Data were extracted on the design, number of participants, participant characteristics, type and dose of H2RA administered, serum alcohol levels (measured as Cmax) along with standard deviations, dose of alcohol received, and fed or fasted status of participants. Alcohol dose was arbitrarily divided into low dose (< or = 0.5 g/kg body weight) versus high dose (> 0.5 g/kg body weight). In addition, studies involving ranitidine and cimetidine were stratified by sample size into small (n < or = 10) versus not small (n > 10).
MEASUREMENTS AND MAIN RESULTS: Twenty-four trials met selection criteria. Small elevations in Cmax were noted when cimetidine (2.71 mg/DL; 95% confidence internal [CI] 1.60, 3.83) or ranitidine (6.95 mg/DL; 95% CI 5.83, 8.08) were coadministered with alcohol. No such differences were noted for famotidine (0.28 mg/DL; 95% CI -1.24, 1.80) or nizatidine (2.33 mg/DL;, 95% CI -0.06, 4.72). The elevation detected with cimetidine and ranitidine was most pronounced in smaller studies (n < 10). Separate analyses investigating the effect of alcohol dose and fed or fasted status of participants revealed no clinically important differences.
CONCLUSIONS: Cimetidine and ranitidine, but not the other H2RAs, can cause small elevations of serum alcohol level when alcohol and drug are administered concurrently. Studies with larger numbers of participants were less likely to demonstrate this effect. Relative to accepted, legal definitions of intoxication, the effect of any H2RA on blood alcohol level is unlikely to be clinically relevant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754514      PMCID: PMC1497018          DOI: 10.1046/j.1525-1497.1998.00181.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  35 in total

1.  Lack of effect of omeprazole, cimetidine, and ranitidine on the pharmacokinetics of ethanol in fasting male volunteers.

Authors:  K A Jönsson; A W Jones; H Boström; T Andersson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Variance imputation for overviews of clinical trials with continuous response.

Authors:  D Follmann; P Elliott; I Suh; J Cutler
Journal:  J Clin Epidemiol       Date:  1992-07       Impact factor: 6.437

3.  Further evidence for an interaction between alcohol and certain H2-receptor antagonists.

Authors:  M Guram; C W Howden; S Holt
Journal:  Alcohol Clin Exp Res       Date:  1991-12       Impact factor: 3.455

4.  Lack of alcohol dehydrogenase isoenzyme activities in the stomach of Japanese subjects.

Authors:  E Baraona; A Yokoyama; H Ishii; R Hernández-Muñoz; T Takagi; M Tsuchiya; C S Lieber
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

5.  The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption.

Authors:  A G Fraser; E J Prewett; M Hudson; A M Sawyerr; S B Rosalki; R E Pounder
Journal:  Aliment Pharmacol Ther       Date:  1991-06       Impact factor: 8.171

6.  Effects of ranitidine on blood alcohol levels after ethanol ingestion. Comparison with other H2-receptor antagonists.

Authors:  C DiPadova; R Roine; M Frezza; R T Gentry; E Baraona; C S Lieber
Journal:  JAMA       Date:  1992-01-01       Impact factor: 56.272

7.  Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol.

Authors:  R H Palmer; W O Frank; P Nambi; J D Wetherington; M J Fox
Journal:  Am J Gastroenterol       Date:  1991-12       Impact factor: 10.864

8.  Ranitidine has no effect on postbreakfast ethanol absorption.

Authors:  A G Fraser; M Hudson; A M Sawyerr; M S Smith; J Sercombe; S B Rosalki; R E Pounder
Journal:  Am J Gastroenterol       Date:  1993-02       Impact factor: 10.864

9.  Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism.

Authors:  A S Brown; J R Fiaterone; C P Day; M K Bennett; P J Kelly; O F James
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

10.  Ranitidine, cimetidine, famotidine have no effect on post-prandial absorption of ethanol 0.8 g/kg taken after an evening meal.

Authors:  A G Fraser; M Hudson; A M Sawyerr; M Smith; S B Rosalki; R E Pounder
Journal:  Aliment Pharmacol Ther       Date:  1992-12       Impact factor: 8.171

View more
  2 in total

Review 1.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

2.  Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012.

Authors:  Manuela G Neuman; Lawrence Cohen; Samir Zakhari; Radu M Nanau; Sebastian Mueller; Michelle Schneider; Charles Parry; Romina Isip; Helmut K Seitz
Journal:  Alcohol Alcohol       Date:  2014-05-09       Impact factor: 2.826

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.